Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (1)
Type
Type
Guidance (263)
NICE advice (26)
Quality standard (13)
Guidance programme
Guidance programme
Cancer service guidelines (5)
Clinical guidelines (17)
Diagnostics guidance (11)
Health technology evaluations (1)
Interventional procedures guidance (43)
Medical technologies guidance (3)
NICE guidelines (23)
Public health guidelines (1)
Social care guidelines (2)
Technology appraisal guidance (182)
Advice programme
Advice programme
Evidence summaries (2)
Medtech innovation briefings (24)
Apply filters
Showing 71 to 80 of 302
Sort by
Date
Title
Apply sorting
Keyword or reference number: cancer
Remove Keyword or reference number: cancer filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast
cancer
TA801
29 June 2022
29 June 2022
Durvalumab for maintenance treatment of unresectable non-small-cell lung
cancer
after platinum-based chemoradiation
TA798
22 June 2022
22 June 2022
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial
cancer
(terminated appraisal)
TA797
15 June 2022
15 June 2022
Tepotinib for treating advanced non-small-cell lung
cancer
with MET gene alterations
TA789
18 May 2022
18 May 2022
Avelumab for maintenance treatment of locally advanced or metastatic urothelial
cancer
after platinum-based chemotherapy
TA788
11 May 2022
11 May 2022
Bladder EpiCheck for detecting bladder
cancer
recurrence
MIB293
3 May 2022
3 May 2022
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast
cancer
after 2 or more anti-HER2 therapies
TA786
27 April 2022
27 April 2022
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal
cancer
TA784
20 April 2022
20 April 2022
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung
cancer
TA781
30 March 2022
30 March 2022
Dostarlimab for previously treated advanced or recurrent endometrial
cancer
with high microsatellite instability or mismatch repair deficiency
TA779
16 March 2022
16 March 2022
Previous page
1
…
6
7
Current page
8
9
10
…
31
Page
8
of
31
Next page
Results per page
10
25
50
All
Back to top